ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thermo Fisher Scientific has signed a definitive agreement to acquire Fermentas International for $260 million in cash. Based in Burlington, Ontario, Fermentas makes enzymes, reagents, and kits for molecular and cellular biology research. It employs about 500 people and had sales last year of $54 million. Thermo CEO Marc N. Casper says the combination of Fermentas, recently acquired Finnzymes, and Thermo’s new Solaris qPCR assays deepens the firm’s polymerase chain reaction market.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter